Skip to main content
Clinical Trials/NCT01711450
NCT01711450
Withdrawn
Not Applicable

Randomised Double Blind Controlled Study of the Effectiveness of Paravertebral Nerve Block in Decreasing Analgesia Requirements and Improving Patient Experience During Interventional Hepatic Procedures.

Richard Lindsay2 sites in 1 countryDecember 2012
ConditionsLiver Neoplasms

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Liver Neoplasms
Sponsor
Richard Lindsay
Locations
2
Primary Endpoint
Dose of intravenous sedation required during and after the procedure
Status
Withdrawn
Last Updated
10 years ago

Overview

Brief Summary

This study is aimed at assessing whether performing a paravertebral block (a type of regional pain relief) can reduce the pain and anxiety patients experience during radiological procedures on the liver.

Detailed Description

Percutaneous procedures of the liver can be very painful and range from bliliary drain insertions to tumor ablation procedures. The study will randomize patients in two groups, one receiving a paravertebral nerve block prior to the procedure and one receiving a sham procedure in which saline will be injected in the paravertebral space. Pain scores and use of IV sedation will be monitored post procedure and both groups will be compared to assess whether paravetebral nerve blocks are effective at reducing pain in patients receiving such procedures.

Registry
clinicaltrials.gov
Start Date
December 2012
End Date
June 2013
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Richard Lindsay
Responsible Party
Sponsor Investigator
Principal Investigator

Richard Lindsay

MD

McGill University Health Centre/Research Institute of the McGill University Health Centre

Eligibility Criteria

Inclusion Criteria

  • Male or non-pregnant female subjects, between the ages of 18 and 80 at the time of enrollment.
  • Subjects referred for liver/biliary interventions to the angiography department.
  • Written informed consent to participate in the study. Ability to comply with the requirements of the study procedures

Exclusion Criteria

  • Subjects who participated in an active stage of any drug, intervention or treatment trial within 30 days of enrollment.
  • Subjects with preexisting conditions, which, in the opinion of the investigator, interfere with the conduct of the study. Patients will only be excluded on this basis following discussion with another interventional radiologist.
  • Subjects who are uncooperative or cannot follow instructions. Mental state that may preclude completion of the study procedure or ability to obtain informed consent.
  • Pregnant or nursing female subjects. Patient who are to undergo liver biopsy or routine biliary tube exchange. Patients with neurological/spinal conditions, or a BMI over 40, that would prevent safe/effective or well-targeted paravertebral blockade.
  • Patient unable to tolerate the paravertebral block procedure, for example due to inability to lie prone

Outcomes

Primary Outcomes

Dose of intravenous sedation required during and after the procedure

Time Frame: 1 hour

Secondary Outcomes

  • Procedure duration(1 hour)
  • Complication rate of liver procedure(24 hours)
  • Complication rate of paravertebral block(1 hour)
  • Improvement in analogue pain scoring after the procedure(1 hour)

Study Sites (2)

Loading locations...

Similar Trials